Global Markets

European Equity pre-Market Summary - 10th September 2026: European bourses set for a mildly firmer open; Porsche AG lifts guidance

StockNow breaking-news AI analysis

European bourses point to a firmer open led by Porsche AG raising cash flow guidance, while healthcare firms Bayer and Roche secure key FDA regulatory milestones.

News detail

Stories: IG Group (IGG LN): Co. is reportedly cutting hundreds of jobs from its 2300 strong workforce. Porsche AG (P911 GY), +0.7%: Announces the sale of its stakes in Bugatti Rimac and Rimac Group for c. EUR 1bln. Co. also raises its FY Automotive Net Cash Flow Margin to +5.5-7.5% (prev. guided 3-5%). Bayer (BAYN GY), +0.5%: Announces that the US FDA has granted accelerated approval for HYRNUO. Roche (ROP SW): Co. announces that the US FDA has granted Priority Review to a supplemental Biologics License Application for Enspryng for the treatment of MOGAD, based on positive results from the Phase III METEOROID study. Broker Moves: BAE Systems (BA/ LN) initiated with Neutral at BNP Paribas. Novartis (NOVN SW), +0.5% upgraded to Hold from Reduce at HSBC. Fortum (FORTUM FH), +0.7% received a broker upgrade at four banks. The numbers after the Co. & ticker are the pre-market indication via Tradegate

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.